Could Alzheimer Disease Be Diabetes Type 3?

Evidence is mounting that links insulin deficiency and insulin resistance to mediation of Alzheimer disease-type neurodegeneration. Get the highlights in these 9 slides.

Recent Content

There are 10 FDA-approved DPP-4 inhibitors--single agents and combination products. Do you speak their language? Find out with these 5 questions.

Spot check your memory for these disease details.

Trade names often mask the essential nature of a medication, but some of the new agents that treat type 2 diabetes take it to a new level. Here, 5 chances to see what you know.

A new post-hoc analysis suggests that what’s good for hyperglycemia may also be good for hyperuricemia.

Triple therapy with albiglutide

In obese patients with type 2 diabetes uncontrolled by lifestyle and two oral agents, albiglutide significantly lowered A1c as part of 3-drug therapy.

At 52 weeks, dulaglutide resulted in significantly greater reductions in HbA1c, FPG, and weight compared with the DPP-4 inhibitor sitagliptin.

Conditions associated with long-term diabetes affect myriad organs and systems. Which one of these comorbidities is not associated with the disease?

By clicking Accept, you agree to become a member of the UBM Medica Community.